Jiangxi Rimag Group Co., Ltd. (HKG:2522)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Medical Labs & Research	873.12M	760.59M	928.91M	784.44M	592.01M
Total	873.12M	760.59M	928.91M	784.44M	592.01M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
China	873.12M	760.59M	928.91M	784.44M	592.01M
Total	873.12M	760.59M	928.91M	784.44M	592.01M

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 10, 2026

Data Sources Report a data error